Skip to main content
Clinical Trials/IRCT20191213045719N1
IRCT20191213045719N1
Recruiting
Phase 3

Comparison of the Effectiveness of intradermal injected tranexamic acid50mg/ml plus ascorbic acid50mg/ml VS tranexamic acid50mg/ml in the treatment of melasma:A split face comparative trial

Ahvaz University of Medical Sciences0 sites24 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
Ahvaz University of Medical Sciences
Enrollment
24
Status
Recruiting
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
Female

Investigators

Eligibility Criteria

Inclusion Criteria

  • Women at the range of 18 to 50 years old
  • patients with symmetrical bilateral melasma

Exclusion Criteria

  • Patient who is pregnant or in lactation period
  • Patient who had taken oral contraceptive pill in 12 months ago
  • Patient who has history of coagulopathy and thrombotic disorder
  • Patient who ia taking anticoagulant and antiepileptic drug
  • Patient who has sensitivity to tranexamic acid
  • Patient who has history of treatment for melasma during 1 month ago
  • Patient who has active facial herpes simplex virus infection
  • Patient who has facial wart

Outcomes

Primary Outcomes

Not specified

Similar Trials